ERas oncogene expression and epigenetic regulation by histone acetylation in human cancer cells

Anticancer Research

Volumn 27, Issue 6 B, 2007, Pages 4071-4075

  Yasuda, Koichi ^a   Yashiro, Masakazu ^a   Sawada, Tetsuji ^a   Ohira, Masaichi ^a   Hirakawa, Kosei ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Epigenetic regulation; Eras; Histone deacetylase inhibitor; Oncogene; Trichostatin A

Indexed keywords

TRICHOSTATIN A;

ACETYLATION; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG MECHANISM; EPIGENETICS; ESOPHAGUS CARCINOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; ONCOGENE; ONCOGENE ERAS; PANCREAS CARCINOMA; PRIORITY JOURNAL; UPREGULATION;

ACETYLATION; CELL LINE, TUMOR; ENZYME INHIBITORS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, RAS; HISTONES; HUMANS; HYDROXAMIC ACIDS; MUTATION; NEOPLASMS; ONCOGENE PROTEIN P21(RAS); RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 37549049305     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Takahashi K, Mitsui K and Yamanaka S: Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. Nature 423: 541-545, 2003.
2. Yashiro M, Nishioka N and Hirakawa K: K-ras mutation influences macroscopic features of gastric carcinoma. J Surg Res 124: 74-78, 2005.
3. Fang JY and Lu YY: Effects of histone acetylation and DNA methylation on p21(WAF1) regulation. World J Gastroenterol 8: 400-405, 2002.
4. Monneret C: Histone deacetylase inhibitors. Eur J Med Chem 40: 1-13, 2005.
5. Karagiannis TC, Smith AJ and EP Osta A: Radio- and chemosensitization of human erythroleukemic K562 cells by the histone deacetylase inhibitor Trichostatin A. Hell J Nucl Med 7: 184-191, 2004.
6. Yashiro M, Carethers JM, Laghi L, Saito K, Slezak P, Jaramillo E, Rubio C, Koizumi K, Hirakawa K and Boland CR: Genetic pathways in the evolution of morphologically distinct colorectal neoplasms. Cancer Res 61: 2676-2683, 2001.
7. Esteller M, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Watkins DN, Issa JP, Sidransky D, Baylin SB and Herman JG: Inactivation of the DNA repair gene 06-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res 60: 2368-2371, 2000.
8. Donadelli M, Costanzo C, Faggioli L, Scupoli MT, Moore PS, Bassi C, Scarpa A and Palmieri M: Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells. Mol Carcinog 38: 59-69, 2003.
9. Joseph J, Wajapeyee N and Somasundaram K: Role of p53 status in chemosensitivity determination of cancer cells against histone deacetylase inhibitor sodium butyrate. Int J Cancer 115: 11-18, 2005.
10. Kitazono M, Bates S, Fok P, Fojo T and Blagosklonny MV: The histone deacetylase inhibitor FR901228 (desipeptide) restores expression and function of pseudo-null p53. Cancer Biol Ther 1: 665-668, 2002.
11. Sandor V, Senderowicz A, Mertins S, Sackett D, Sausville E, Blagosklonny MV and Bates SE: P21-dependent G(1)arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228. Br J Cancer 83: 817-825, 2000.
12. Fasano O, Aldrich T, Tamanoi F, Taparowsky E, Furth M and Wigler M: Analysis of the transforming potential of the human H-ras gene by random mutagenesis. Proc Natl Acad Sci USA 81: 4008-4012, 1984.
13. Vairaktaris E, Papageorgiou G, Derka S, Moulavassili P, Nkenke E, Kessler P, Vassiliou S, Papakosta V, Spyridonidou S, Vylliotis A, Lazaris AC, Anagnostopoulou S, Mourouzis C, Yapijakis C and Patsouris E: Expression of ets-1 is not affected by N-ras or H-ras during oral oncogenesis. J Cancer Res Clin Oncol 133: 227-233, 2007.